1
Cesar Alaniz, Pharm.D.
CURRICULUM VITAE
Cesar Alaniz, Pharm.D.
715 Braeside Place
Ann Arbor, MI 48103
(734) 663-4871 (home)
(734) 936-2244 (work)
EDUCATION
1985-1986 / ASHP Accredited Residency in Clinical PharmacyVeterans Administration Medical Center
Ann Arbor, Michigan
1981-1985 / Doctor of Pharmacy
University of California
San Francisco, California
1978-1980 / Bachelor of Arts – Pharmacology
University of California
Santa Barbara, California
LICENSURE
June, 1986 / MichiganPHARMACY PRACTICE EXPERIENCE
1995-Present / CLINICAL PHARMACISTADULT MEDICINE INTENSIVE CARE UNIT
University of Michigan Health System
Ann Arbor, Michigan
1996-July, 1999 / CLINICAL PHARMACIST TEAM LEADER
Department of Pharmacy Services
University of Michigan Health System
Ann Arbor, Michigan
1986-1995 / CLINICAL PHARMACIST
ADULT INTERNAL MEDICINE
University of Michigan Medical Center
Ann Arbor, Michigan
ACADEMIC APPOINTMENTS
2002-Present / CLINICAL ASSOCIATE PROFESSORCollege of Pharmacy
University of Michigan, Ann Arbor
1989-Present / CLINICAL ASSISTANT PROFESSOR
College of Pharmacy
University of Michigan, Ann Arbor
1985-1989 / CLINICAL INSTRUCTOR
College of Pharmacy
University of Michigan, Ann Arbor
TEACHING EXPERIENCE: COURSES COORDINATED
2011- / Direct Patient CareCollege of Pharmacy
University of Michigan, Ann Arbor
2008- / Introduction to Critical Care Pharmacotherapy
College of Pharmacy
University of Michigan, Ann Arbor
1990-1999 / "Clinical Pharmacokinetics"
College of Pharmacy
University of Michigan, Ann Arbor
1987-91 / "Drug Therapy of Parasitic Diseases"
College of Pharmacy
University of Michigan, Ann Arbor
TEACHING EXPERIENCE: LECTURES GIVEN
2008- / Introduction to Critical Care Pharmacotherapy – “Introduction, ARDS, Acute Liver Failure”College of Pharmacy
University of Michigan, Ann Arbor
1993-2007 / "Clinical Therapeutics – Liver Disease"
College of Pharmacy
University of Michigan, Ann Arbor
2000-2004 / “Drug Use Evaluation”
College of Pharmacy
University of Michigan, Ann Arbor
1991-1998 / "Clinical Pharmacology and Therapeutics – Dosing Considerations in Disease States"
School of Medicine
University of Michigan, Ann Arbor
1990-1999 / "Phenytoin and Cyclosporine Pharmacokinetics"
College of Pharmacy
University of Michigan, Ann Arbor
1991 / "Sexually Transmitted Diseases"
School of Nursing
University of Michigan, Ann Arbor
1987-91 / "Drug Therapy of Parasitic Diseases"
College of Pharmacy
University of Michigan, Ann Arbor
1987-90 / "Clinical Therapeutics - Management of Seizures"
College of Pharmacy
University of Michigan, Ann Arbor
1989, 1990 / "Oral Diagnosis - Drugs Used in Dentistry"
School of Medicine
University of Michigan Medical Center
1986 / "Introduction to Patient Monitoring"
College of Pharmacy
University of Michigan, Ann Arbor
AWARDS
2008-09 / TEACHING EXCELLENCE AWARDGiven by 4-year pharmacy class
College of Pharmacy
University of Michigan, Ann Arbor
1998 / PRECEPTOR OF THE YEAR
College of Pharmacy
University of Michigan, Ann Arbor
COMMITTEES – HOSPITAL
2013- / ALCOHOL WITHDRAWAL GUIDELINES COMMITTEEUniversity of Michigan Health System, Ann Arbor
2009- / ANTICOAGULATION COMMITTEE
University of Michigan Health System, Ann Arbor
2010 / ANTICOAGULATION CLINICAL PHARMCIST SEACH COMMITTEE
University of Michigan Department of Pharmacy
1997-Present / PHARMACY AND THERAPEUTICS COMMITTEE
University of Michigan Health System, Ann Arbor
1996-Present / CRITICAL CARE STEERING COMMITTEE
University of Michigan Health System, Ann Arbor
1995-Present / MEDICAL ICU MULTIDISCIPLINARY COMMITTEE
University of Michigan Health System, Ann Arbor
2005-2006 / TIMED BLOOD DRAWS LEAN TEAM
University of Michigan Health System, Ann Arbor
2005-2006 / DVT RISK ASSESSMENT AND PROPHYLAXIS
University of Michigan Health System, Ann Arbor
2005-2006 / HEPARIN ORDERS MANAGEMENT PROJECT
University of Michigan Health System, Ann Arbor
2005-2006 / SMOKING CESSATION POLICY
University of Michigan Health System, Ann Arbor
2004 / CHAIR, PHARMACY CARDIOLOGY SEARCH COMMITTEE
University of Michigan Health System, Ann Arbor.
1997-2001 / QUALITY IMPROVEMENT COMMITTEE
Department of Pharmacy Services
University of Michigan Health System, Ann Arbor
1996-2001 / CHAIRPERSON, RESIDENCY ADVISORY COMMITTEE
University of Michigan Health System, Ann Arbor
1996-1997 / IV STANDARDIZATION COMMITTEE
University of Michigan Health System, Ann Arbor
1989-1996 / DRUG UTILIZATION EVALUATION COMMITTEE
University of Michigan Hospitals, Ann Arbor
1991-1995 / CLINICAL TOTAL QUALITY IMPROVEMENT TEAM
Appropriate Therapeutic Drug Monitoring
University of Michigan Hospitals, Ann Arbor
1992-1994 / BLOOD DRAW QUALITY IMPROVEMENT TEAM
Appropriate Utilization of Phlebotomy Personnel
University of Michigan Hospitals, Ann Arbor
COMMITTEES - COLLEGE OF PHARMACY
2009-Present / ADMISSIONS COMMITTEEUniversity of Michigan College of Pharmacy
2004-Present / PHARM D. INVESTIGATIONS COMMITTEE
University of Michigan College of Pharmacy
2012 / CHAIR, GENERAL SURGERY/NUTRITION SUPPORT
SEARCH COMMITTEE
University of Michigan College of Pharmacy
2005-2006 / SURGICAL ICU SEARCH COMMITTEE
University of Michigan College of Pharmacy
2005-2006 / FACULTY EVALUATION AND DEVELOPMENT COMMITTEE
University of Michigan College of Pharmacy
2004 / AD-HOC PROMOTIONS COMMITTEE
University of Michigan College of Pharmacy
2003 / MEMBER, DEAN SEARCH ADVISORY COMMITTEE
2003 / MEMBER, DRUG INFORMATION SEARCH COMMITTEE
2000-Present / CLINICAL RESEARCH REVIEW COMMITTEE
2002 / CHAIR, PROMOTIONS AD-HOC COMMITTEE
1999-2000 / CHAIR, PHARMACY TRANSPLANT SURGERY SEARCH COMMITTEE
1999 / CHAIR, PHARMACY GENERAL SURGERY SEARCH COMMITTEE
1999 / DEPARTMENTAL CHAIR SEARCH COMMITTEE
COMMITTEES – NATIONAL
December 12-13, 2002 / MEMBER, ADVISORY COMMITTEE for EPCP, Emerging Pathogens Consult Program2000-2003 / MEMBER, PROGRAM COMMITTEE of the Clinical Pharmacy/Pharmacology Section of Society of Critical Care
November 10-11, 2000 / MEMBER, ADVISORY COMMITTEE for EPIC, Emerging Pathogens and Interventions for Clinicians, West Palm Beach, FL.
COMMITTEES – REGIONAL
2008- / MEMBER, ADVISORY COMMITTEE for Keystone Surviving Sepsis CampaignMichigan Hospitals Association
PROFESSIONAL ACTIVITIES
January 2010, 2012, 2013 / MODERATOR, POSTER SESSIONSSociety of Critical Care Medicine Annual Congress
Miami, FL
2008-Present / REVIEWER, ABSTRACTS
Society of Critical Care Medicine Annual Congress
2011-Present / REVIEWER, BIOMEDICAL CENTRAL: GERIATRICS
2004- Present / REVIEWER, P & T
1994-Present / REVIEWER, THE ANNALS OF PHARMACOTHERAPY
1998-Present /
REVIEWER, THE JOURNAL OF PHARMACY TECHNOLOGY
1999-Present / REVIEWER, THE JOURNAL OF MANAGED CARE2005 / Chapters Reviewed: Drugs Affecting the Cardiovascular and Renal Systems in Drugs and the Nursing Process, Elsevier, 2005.
1993-1997 / REVIEWER, POSTER PRESENTATIONS
The American Society of Health-System Pharmacy
PRESENTATIONS AND LECTURES
“Impact of body weight on albumin replacement in patients with spontaneous bacterial peritonitis.” Harrison M, Leung J, Shen K, Regal R, Alaniz C. Poster Presentation at the Society of Critical Care Medicine Congress, San Juan, PR, January 2013.
“Impact of body weight on potassium replacement in critically ill patients.” Koors M, Truong V, Pleva M, Dorsch M, Alaniz C, Hyzy RC.. Poster Presentation at the Society of Critical Care Medicine Congress, San Juan, PR, January 2013.
“Comparison of clinical outcomes with azithromycin and fluoroquinolones in the treatment of legionella pneumonia.” Rarus R, Crowley A, Nagel J, Alaniz C. Poster Presentation at the Society of Critical Care Medicine Congress, San Juan, PR, January 2013.
“Evaluating the efficacy and complications of chemoprophylaxis for venous thromboembolism in otolaryngology”. Bahl V, Shuman AG, Hsou M, Jackson CR, Alaniz C, Chepeha DB, Bradford CR. Poster presentation at the International Conference on Head and Neck Cancer, Toronto, ON, Canada, July 2012.
“Five year experience with hydrocortisone use for septic shock.” Edwin S, Nielsen J, Brach L, Strachan K, Alaniz C, Hyzy RC. Poster Presentation at the Society of Critical Care Medicine Congress, Houston, TX, January 2011.
“Therapeutic anticoagulation with enoxaparin in obese patients” Edwin S, Nielsen J, Mehta V, Dorsch M, Alaniz C. Poster Presentation at the Society of Critical Care Medicine Congress, San Diego, CA, January 2011.
“Incidence of Hypoglycemia Associated with Less Intensive Insulin Therapy: Depends on the Definition of Hypoglycemia.” Pleva M, Widlicki M, Brach C, Strachan CL, Alaniz C, Hyzy RC, Poster Presentation at the Society of Critical Care Medicine Congress, Miami, FL, January 2010.
“Vasopressor Selection and Maximum Infusion Rates in Septic Shock.” Pollard S, Pleva M, Hyzy RC, Alaniz C, Poster Presentation at the Society of Critical Care Medicine Congress, Miami, FL, January 2010.
“Applicability of the Rumack-Matthew Nomogram to a Pediatric Population.” Toderico A, Ebaugh S, Stumpf JL, Alaniz C. Poster Presentation at the American Society of Health Systems Pharmacists Midyear Clinical Meeting, Anaheim, CA, December, 2009.
“Does body weight impact the efficacy of vasopressin the management of septic shock?” Miller JT, Alaniz C, Kraft MD, Welage LS. Poster Presentation at the Society of Critical Care Medicine Congress, Nashville, TN, February, 2009.
“Comparison of IV metoprolol continuous infusion versus intermittent infusion in surgical intensive care unit patients.” Kraft MD, Alaniz C, Hayanga AJ, et. al. Poster Presentation at the American College of Clinical Pharmacy Meeting, Pheonix, AZ, April, 2008.
“Acetaminophen induced liver failure: epidemiology, management and need for increased awareness.” Alaniz C, Erickson SR, Dietz H. Presentation, Michigan Pharmacist Association Annual Convention and Exposition, Dearborn, MI. February, 2008.
“Evaluating accuracy of diagnosing heparin-induced thrombocytopenia in a University Hospital. Mohammad D, Lindquist K, Lewandowski A, Alaniz C, Stevenson J. Poster Presentation at the Society of Critical Care Medicine Meeting, Honolulu HI, February, 2008.
“Octreotide versus octreotide and continuous infusion pantoprazole in the treatment of variceal hemorrhage.” Mohammad R, Smigel J, Tripp B, Welage L, Alaniz C. Poster Presentation at the American College of Clinical Pharmacy Meeting, Memphis TN, April, 2007.
“Clostridium difficile associated disease.” Invited presentation, Michigan Pharmacist Association Annual Convention and Exposition, Dearborn, MI, March, 2007
“Impact and compliance with a protocol for Factor VIIa use.” Mohammad D, Stevenson J, Butler S, Alaniz C. Poster Presentation at the Society of Critical Care Medicine Annual Congress, Orlando, FL, February, 2007.
“DVT Prevention – Can We Do Better? Implementing a Risk Assessment Tool to Improve Adherence to Guidelines for Medical Inpatients.” Bump G, Alaniz C. Poster Presentation at Society of Hospitalists Medicine Meeting, Washington D.C., May, 2006.
“Increased length of stay in medical intensive care unit associated with vancomycin-resistant enterococci surveillance.” Alaniz C, Arndt J, Brach C, Adamczyk M., Hyzy R, McClish D, Hay J, Lenart P. Poster Presentation at the Society of Critical Care Medicine Meeting, San Francisco, CA, Jan 2006.
“Outcome of an insulin infusion protocol on blood glucose control in patients undergoing cardiac surgery.” Khanderia, U. Iaderosa, R. Edillo, NP. Alaniz, C. Gianchandani, R. Poster presentation at the ASHP Midyear Clnical Meeting, Las Vegas, NV, Dec, 2005.
“Judicious Use of Antibiotics in Hospital Acquired Pneumonia” St. Joseph’s Mercy Hospital, Ypsilanti, MI April 25, 2005.
“The impact of educational interventions on the use of serum cyanide concentrations in patients receiving nitroprusside.” Alaniz C, Caruthers R, Butler SO. Poster Presentation at the Society of Critical Care Medicine Meeting, Phoenix, AZ, Jan 2005.
“Use and satisfaction of daily goals for patients in a medical intensive care unit.” Adamczyk M., Hyzy R, Bria B, Campbell DA, Thompson M., Strachan C, Brach C, Keesler C, McClish D, Hay J, Lenart P, Alaniz C. Poster Presentation at the Society of Critical Care Medicine Meeting, Phoenix, AZ, Jan 2005.
“Discordance of international classification of diseases, 9th edition (ICD-9) coding for severe sepsis at a university hospital.” Butler SO, Nielsen J, Alaniz C, Welage LS. Poster Presentation at the Society of Critical Care Medicine Meeting, Phoenix, AZ, Jan 2005.
Impact of a continuous insulin infusion protocol on sternal wound infections in patients undergoing cardiac surgery. Khanderia U, Edillo PN, Iaderosa R, Alaniz C. Poster presentation at the ASHP Midyear Clinical Meeting Orlando, FL, Dec, 2004.
“Steroids in Sepsis” Surviving Sepsis Campaign: Making it a Reality in Michigan, Brighton, MI. November 6, 2004.
“Extended Spectrum Beta-Lactamases” St. Joseph’s Mercy Hospital, Ypsilanti, MI September 16, 2004.
“Pseudomonas aeruginosa and acinetobacter baumanii” Select Specialty, Mt. Clemens, MI. April 24, 2004..
“Vancomycin Resistant Enterococcus”, Detroit Receiving Hospital, Detroit, MI. December 18, 2003.
“Knowledge of acetaminophen doses and potential toxicities in an adult clinic population.” Skyles AG, Stumpf JL, Alaniz C, Erickson S. Poster presentation at the ASHP Midyear Clnical Meeting, New Orleans, LA, Dec 2003..
Fedewa K, Collins CD, Alaniz C. Compliance with institutional guidelines on the use of vancomycin in a medical intensive care unit. Poster presentation at the ASHP Midyear Clinical Meeting. New Orleans, LA, Dec,2003.
Janusz, JL. Alaniz, C. Etiologies and outcomes of patients admitted to a university hospital with presumed acetaminophen toxicity. Poster presentation at the ASHP Midyear Clinical Meeting. New Orleans, LA, Dec, 2003
“Pseudomonas aeruginosa and acinetobacter baumanii” St. Joseph’s Mercy Hospital, Ypsilanti, MI. November 7, 2003.
“Antibiotic selection in the management of nosocomial pneumonia” CCMU Nursing Education, UMHS. October 22, 2003.
"Multi-drug resistance" Oakwood Hospital, Dearborn, MI. September 18, 2003.
“Review of fungal isolates over a 7-year period in medical, surgical and trauma-burn units in a university hospital.” Alaniz C, Depestel D, Pierson C. Poster presentation at the Society of Critical Care Medicine Educational and Scientific Symposium. San Antonio, TX January 28, 2003.
“Management of Febrile Neutropenia” Grand Rounds presented at Bronson Medical Center, Kalamazoo, MI, February 5, 2003.
“Update on Esophageal Varices” Platform presentation at the ASHP Midyear Clinical Meeting, December 10, 2002.
“Toxicology” CE Presentation to MICU nurses, University of Michigan Health System, Ann Arbor, October 7 and 11, 2002.
“C. Difficile Associated Disease” CE Presentation, Emerging Pathogens and Interventions for Clinicians Symposium. Lake Geneva, WI, July 19, 2002
“Resistance in the ICU”, Lecture presented to Clinical staff, Oakwood Hospital, Southfield, MI, August 28, 2001.
“Pseudomonas resistance”, Presented to clinical staff, Chelsea Hospital, Chelsea, MI, October 24, 2001.
“Vancomycin Resistant Enterococcus”, Emerging Pathogens and Interventions for Clinicians Symposium. Novi, MI, November 17, 2001.
“Susceptibility of Pseudomonas aeruginosa Isolates to Fluoroquinolones in a Medical IntensiveCare Unit: The Need for Unit-Specific Data.” Alaniz C, Depestel D, Pierson C. Poster presentation at the Society of Critical Care Medicine Educational and Scientific Symposium. San Diego, CA January 28, 2002.
“Continuous Beta-lactam Infusions”, Presented to clinical staff, Ivyonix Corporation. Livonia, MI, August 21, 2001.
"Choice of Sedative and a Continous Infusion Sedation Protocol: Impact on Outcomes and Healthcare Costs in a Medical Intensive Care Unit. Kuru T, Alaniz C, Kewman S, Diccion S, Toews G, Watts C. Poster Presentation at the Society of Critical Care Medicine Educational and Scientific Symposium. San Francisco, CA, February 13, 2001.
“Issues in Antibiotic Therapy”, Presentation at the Medical-Surgical Nursing Conference, Ann Arbor, MI, April 28, 2000.
"Choice of Sedative Agent in Patients with ARDS Undergoing Low Tidal Volume Mechanical Ventilation,” Kuru T, Alaniz C, Kewman S, Strachan C, Diccion S, Toews G, Watts C. Poster presentation at the SCCM Educational and Scientific Symposium. Orlando, FL, February 15, 2000.
"Piperacillin-Tazobactam: Review and Outlook” Presentation to Infectious Disease Service, Henry Ford Hospital, Detroit, MI, October 22, 1999.
“Antibiotics in the ICU”, One-hour CE program presented to Critical Care Medicine Unit, University of Michigan Health System, Ann Arbor, MI, October 11, 1999.
"Use of Broad-Spectrum Antibiotics in the ICU” Presentation at HomeMed, Ann Arbor, MI, May 6, 1999.
“Implementation of Single Daily Dose Aminoglycosides to Reduce the Incidence of Nephrotoxicity in Critically Ill Patients,” Odeh R, Alaniz C, Hayes S. Poster presentation at the ACCP International Meeting, Orlando, FL, April 14, 1999.
"Management of Hypertensive Emergencies in a University Hospital,” Klepack E, Alaniz C, Stumpf JL. Poster presentation at the ASHP Midyear Clinical Meeting, Las Vegas NV, December 9, 1998.
"Single Daily Dose Aminoglycosides and the Incidence of Nephrotoxicity in Critically Ill Patients,” Odeh R, Alaniz C, Hayes S. Poster presentation at the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 6, 1998.
"Antibiotic Selection and Emergence of VRE.” Presented to General Surgery Residents, University of Michigan Health System, Ann Arbor, MI, August 8, 1998.
"Update on Antimicrobial Therapy.” Alaniz C. Presentation at Ivonyx-Complete Infusion Co., Livonia MI, May 12, 1998.
"Once Daily Aminoglycoside Administration in Intensive Care Units,” Odeh R, Alaniz C, Hayes S. Platform presentation at the Institute for Healthcare Improvement Annual Meeting, Atlanta, GA, November 13, 1998.
"Vancomycin Resistant Enterococcus,” CME presentation at the Community Health Center of Branch County, Coldwater, MI, March 18, 1998.
"Antibiotic Selection in the ICU.” Alaniz C. Presentation to the Pulmonary Critical Care Associates of Ann Arbor, Ypsilanti, MI January 16, 1998.
"Sedation in the ICU” Alaniz C. Presentation to Oakwood Hospital Pharmacists, Dearborn, MI, December 5, 1997.
"Antibiotic Algorithms in the Medical ICU.” Alaniz C. presentation to Mercy Hospital Pharmacists, St. Clair, MI, September 10, 1997.
"Pharmacoeconomics in the Intensive Care Unit,” Alaniz C. CE presentation at the American Association of Critical Care Nurses Meeting, Novi, MI, May 8, 1997.
"Determination and Evaluation of the Therapeutic Range of Serum Phenytoin Concentrations at a University Hospital. Alaniz C, Sony A. Poster presentation at the ASHP Midyear Clinical Meeting, New Orleans, LA, December 10, 1996.
"Cost-effective Use of Neuromuscular Blocking Agents and Sedative Hypnotic Drugs in the ICU,” Watts C, Strachan C, Guglielmo D, Chaffee B, Alaniz C, Diccion S, Kewman S. Poster presentation at the Institute for Healthcare Improvement Annual Meeting, Boston, MA, December 12, 1996.
"What is the Association Between Corticosteroid Use and Peptic Ulcer Disease?" Alaniz C. CE presentation at the Michigan Pharmacist Association Interim Meeting, Dearborn, MI, February 21, 1993."Evaluation of Intravenous Phosphorous Replacement in a University Hospital," Alaniz C, Rice TL. Poster presentation at the ASHP Midyear Clinical Meeting, Orlando, FL, December 8, 1992.
"Overview of Basic Pharmacokinetics," Alaniz C. Presentation at the American Association for Clinical Chemistry Meeting, Dearborn, MI, November 19, 1992.
"Treatment of Acute Severe Hypophosphatemia,” Alaniz C. CE presentation at the Michigan Pharmacist Association Interim Meeting, Dearborn, MI, February 23, 1992.
"Computer-Assisted Monitoring and Pharmacist-Initiated Modification of Excessive Imipenem-Cilastatin Dosing," Townsend KA, Alaniz C, Ryan ML, et al. Platform presentation at the ASHP Annual Meeting, San Diego, CA, June 4, 1991.
"Imipenem-Cilastatin Use in University Hospital: Evaluation of Dosing and Survey of Adverse Effects," Townsend KA, Alaniz C, Stumpf JL. Poster presentation at the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 6, 1990.
"The Use of Norfloxacin in a University Hospital," Alaniz C, Stumpf JL, Townsend KA. Poster presentation at the ASHP Midyear Clinical Meeting, Atlanta, GA, December 5, 1989.
RESEARCH
Alaniz C, Edwin S, Nielsen J, Mehta V, Dorsch M. Dosing of enoxaparin in obese patients: a population pharmacokinetic analysis.
Alaniz C, Larkin A, Dorsch M, Pleva M, Btaiche I. Impact of body weight on potassium replacement in critically ill patients.
Alaniz C, Regal RR. Evaluation of albumin infusions in patients with spontaneous bacterial peritonitis.
Nagel J, Alaniz C. Retrospective evaluation of azithromycin versus levofloxacin in the management of legionella pneumonia.
GRANTS
Alaniz, C. 2005, Grant, Amgen Inc. ASSESS Study: $28,156.25
Alaniz, C. 2004, Unrestricted grant, Wyeth Pharmaceuticals: $2,000.
Lynda Welage, Cesar Alaniz, Jessica Ellis, Robert Hyzy, Andrea Mitchell, Carol Kauffman. 2003, Grant, Pharmacia Corporation: $57,702.
Alaniz, C. 2003, Unrestricted grant, Lilly Corporation: $500.
Alaniz, C. 2003, Unrestricted grant, Wyeth Pharmaceuticals: $1,000.
Depestel D, Alaniz C. 2001, Unrestricted grant, Otho-McNeil Corporation: $4,000
Alaniz C, Depestel D. 2001, Unrestricted grant, Wyeth Pharmaceuticals: $5,000
PUBLICATIONS
Mohammad RA,Regal R, Alaniz C. Combination therapy for the treatment and prevention of hepatic encephalopathy. Ann Pharmacother 2012; 46:1559-63.